Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of “Buy” by Analysts
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have received a consensus recommendation of “Buy” from the eight research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating on the […]
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have received a consensus recommendation of “Buy” from the eight research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating on the […]
